Lupron, one of the drugs commonly used in the practice of ovarian stimulation procedures, is one of the baddies which the FDA should investigate. Actually, I have called upon people in higher powers to ask the FDA to investigate the 1000s of 1000s of Lupron related complaints and Lupron related deaths they already have sitting on their desk. But so far, to no avail.

I received this from someone yesterday on “what your doctor doesn’t tell you about Lupron”.

“It is unfortunate that the many patients suffering long-term negative effects of this drug are disbelieved by society and the medical industry. This may be due largely to the fact that Lupron® is among the most widely promoted drugs. The PR and marketing giant known as Takeda Abbott Pharmaceuticals spends billions of dollars advertising and promoting this drug every year, as well as providing enticing incentives to physician to prescribe it to their patients.”

And this (I’ve heard rumors that IVF specialists get nice paybacks for giving these drugs).

“Of greater concern is the practice by which the drug is peddled. Your doctor may not have told you that in a recent federal lawsuit, TAP pleaded guilty and paid out over a staggering *$875 million* in criminal fines, restitution and civil penalties for their illegal marketing, pricing manipulations, and unethical sales practices to induce doctors to prescribe Lupron®. The suit, brought under the federal Racketeer Influenced & Corrupt Organizations Act (RICO) represents the largest pharmaceutical fine in history.”

Lupron is a category X drug too, which means, do not get pregnant while taking this drug.

Author Profile

Jennifer Lahl, CBC Founder
Jennifer Lahl, CBC Founder
Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.